Apollo Hospitals Share Price Surges 5% on Strong Q3 FY26 Performance | Stock Market Today

Apollo Hospitals share price jumped over 5% to ₹7,580 per share on Wednesday, reflecting investor optimism following its robust Q3 FY26 earnings. The stock opened at ₹7,410 in early trading, up from Tuesday’s close of ₹7,219, as the healthcare giant showcased strong operational performance across its segments.

Market Performance

The broader market saw mixed trends, but Apollo Hospitals stood out with its sharp gains. The stock’s 5% rise highlighted confidence in the company’s fundamentals and operational resilience. The surge came amid strong quarterly numbers, reflecting healthy revenue growth, profitability, and improved margins.

Apollo Hospitals Q3 FY26 Results

Apollo Hospitals reported solid financial results for the quarter ending December 31, 2025. Key highlights include:

• Consolidated Revenue: ₹6,477 crore, up 17% YoY from ₹5,527 crore in Q3 FY25.
• EBITDA: ₹965 crore, a 27% rise from ₹762 crore, after accounting for Apollo 24/7 expenses of ₹124 crore.
• Net Profit: ₹502 crore, a significant 35% YoY increase.

The quarter demonstrated strong performance across the company’s core operations, supported by higher occupancy, improved case mix, and operational efficiencies.

Segment-Wise Performance

Healthcare Services Segment

Apollo’s healthcare services division continued to drive growth:

• Revenue: ₹3,183 crore, up 14% YoY from ₹2,785 crore.
• EBITDA: ₹790 crore, an 18% increase.
• Margins: Improved to 24.8%.
• Net Profit: ₹422 crore, up 21%.

Growth in this segment was fueled by better hospital occupancy, efficient cost management, and higher-value procedures.

Apollo Health and Lifestyle (AHLL)

The AHLL segment also delivered encouraging results:

• Revenue: ₹467 crore, up 20% YoY.
• EBITDA: ₹48 crore, rising 39%, with margins expanding to 10.2%.
• Net Loss: ₹6 crore, narrowing from ₹8 crore in Q3 FY25.

This segment benefited from pharmacy expansion and growth in digital platforms, gradually reducing losses while improving profitability.

Key Developments and Operational Highlights

Apollo Hospitals’ Q3 performance reflected its deep clinical capabilities and integrated care approach:

• Apollo OMR completed 150 robotic joint replacement surgeries in 150 days.
• Expansion of stroke care network in Chennai with nine advanced stroke labs, enhancing rapid access care and outcomes.
• Continued focus on patient safety, quality, and experience, driving operational efficiencies.

Additionally, the company announced an interim dividend of ₹10 per share for FY26, reflecting confidence in cash flow and financial stability.

Summary

Apollo Hospitals’ Q3 FY26 results underscore the company’s broad-based growth and operational strength:

• Consolidated revenue rose 17% YoY to ₹6,477 crore.
• EBITDA increased 27% to ₹965 crore, reflecting strong operating leverage.
• Net profit jumped 35% YoY to ₹502 crore.
• Core hospital operations remain the primary growth driver, with 24.8% EBITDA margins and rising case complexity.
• AHLL segment shows margin improvement and narrowing losses, highlighting emerging scalability.

The stock’s performance aligns with its solid fundamentals, strong balance sheet, and healthy operational metrics. Apollo Hospitals continues to demonstrate resilience, operational discipline, and clinical excellence, reinforcing its position as a leading integrated healthcare provider in India.

Source: Livemint